213 related articles for article (PubMed ID: 23633584)
41. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
[TBL] [Abstract][Full Text] [Related]
42. The impact of oncogenic mutations of the viral Src kinase on the structure and stability of the SH3 domain.
Salinas-Garcia MC; Plaza-Garrido M; Camara-Artigas A
Acta Crystallogr D Struct Biol; 2021 Jun; 77(Pt 6):854-866. PubMed ID: 34076598
[TBL] [Abstract][Full Text] [Related]
43. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
Larson SM; Davidson AR
Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
[TBL] [Abstract][Full Text] [Related]
44. Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling.
Ladbury JE; Arold ST
Methods Enzymol; 2011; 488():147-83. PubMed ID: 21195228
[TBL] [Abstract][Full Text] [Related]
45. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
[TBL] [Abstract][Full Text] [Related]
46. Src protein-tyrosine kinase structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
[TBL] [Abstract][Full Text] [Related]
47. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
48. Post-translational modification of the N-terminal His tag interferes with the crystallization of the wild-type and mutant SH3 domains from chicken src tyrosine kinase.
Kim KM; Yi EC; Baker D; Zhang KY
Acta Crystallogr D Biol Crystallogr; 2001 May; 57(Pt 5):759-62. PubMed ID: 11320329
[TBL] [Abstract][Full Text] [Related]
49. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
50. High-resolution structure of the diphtheria toxin repressor complexed with cobalt and manganese reveals an SH3-like third domain and suggests a possible role of phosphate as co-corepressor.
Qiu X; Pohl E; Holmes RK; Hol WG
Biochemistry; 1996 Sep; 35(38):12292-302. PubMed ID: 8823163
[TBL] [Abstract][Full Text] [Related]
51. The Two Isoforms of Lyn Display Different Intramolecular Fuzzy Complexes with the SH3 Domain.
Teixeira JMC; Fuentes H; Bielskutė S; Gairi M; Żerko S; Koźmiński W; Pons M
Molecules; 2018 Oct; 23(11):. PubMed ID: 30360468
[TBL] [Abstract][Full Text] [Related]
52. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
53. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
54. Interfacial water molecules in SH3 interactions: a revised paradigm for polyproline recognition.
Martin-Garcia JM; Ruiz-Sanz J; Luque I
Biochem J; 2012 Mar; 442(2):443-51. PubMed ID: 22115123
[TBL] [Abstract][Full Text] [Related]
55. Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3.
Kokoszka ME; Kall SL; Khosla S; McGinnis JE; Lavie A; Kay BK
J Biol Chem; 2018 Aug; 293(35):13553-13565. PubMed ID: 29980598
[TBL] [Abstract][Full Text] [Related]
56. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides.
Musacchio A; Saraste M; Wilmanns M
Nat Struct Biol; 1994 Aug; 1(8):546-51. PubMed ID: 7664083
[TBL] [Abstract][Full Text] [Related]
57. Differential sensitivity of Src-family kinases to activation by SH3 domain displacement.
Moroco JA; Craigo JK; Iacob RE; Wales TE; Engen JR; Smithgall TE
PLoS One; 2014; 9(8):e105629. PubMed ID: 25144189
[TBL] [Abstract][Full Text] [Related]
58. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide.
Ogura K; Nobuhisa I; Yuzawa S; Takeya R; Torikai S; Saikawa K; Sumimoto H; Inagaki F
J Biol Chem; 2006 Feb; 281(6):3660-8. PubMed ID: 16326715
[TBL] [Abstract][Full Text] [Related]
59. Expression, purification and preliminary crystallographic studies of the C-terminal SH3 domain of human Tks4.
Huang Y; Qian H; Wang X; Cheng Z; Ren J; Zhao W; Xie Y
Acta Crystallogr F Struct Biol Commun; 2014 Mar; 70(Pt 3):343-6. PubMed ID: 24598923
[TBL] [Abstract][Full Text] [Related]
60. Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism.
Pérez Y; Maffei M; Igea A; Amata I; Gairí M; Nebreda AR; Bernadó P; Pons M
Sci Rep; 2013; 3():1295. PubMed ID: 23416516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
